Published in Recenti Prog Med on November 01, 1984
An Italian family affected by Nasu-Hakola disease with a novel genetic mutation in the TREM2 gene. J Neurol Neurosurg Psychiatry (2003) 1.22
Melatonin and cortisol circadian secretion during ethanol withdrawal in chronic alcoholics. Chronobiologia (1994) 0.88
Circadian variations of human flexion reflex. Pain (1986) 0.87
A cooperative study of epirubicin with cyclophosphamide, vincristine and prednisone (CEOP) in non-Hodgkin's lymphoma. Haematologica (1995) 0.83
[Topical treatment of thrombophlebitis with feprazone and benzydamine. Controlled clinical study]. Minerva Med (1976) 0.82
Study of factors affecting the determination of total plasma 7-fluorobenzo-2-oxa-1,3-diazole-4-sulfonate (SBD)-thiol derivatives by liquid chromatography. J Chromatogr B Biomed Sci Appl (1998) 0.82
[Plasmocytoma of the testis. Description of a clinical case and review of the literature]. Minerva Med (1993) 0.82
Primary cardiac lymphoma. A case report and review. Minerva Cardioangiol (1999) 0.81
Bone marrow biopsy for the staging of non-Hodgkin's lymphoma: bilateral or unilateral trephine biopsy? Tumori (1996) 0.80
Influence of different anaesthetics on extracellular aminoacids in rat brain. J Neurosci Methods (2000) 0.80
Familial hemiplegic migraine versus migraine with prolonged aura: an uncertain diagnosis in a family report. Neurology (1995) 0.80
Changes in diagnostic approach and factors affecting treatment and survival of pancreatic carcinoma in a retrospective series over twelve years. Tumori (1994) 0.79
Chronic lead treatment induces in rat a specific and differential effect on dopamine receptors in different brain areas. Brain Res (1981) 0.79
Chiropractic complications. Another case report. Acta Neurol (Napoli) (1993) 0.78
Reference values of neuroactive amino acids in the cerebrospinal fluid by high-performance liquid chromatography with electrochemical and fluorescence detection. J Chromatogr A (1996) 0.77
Clinical MRI dissociation in myelopathy: a clue to sarcoidosis? J Neurol Neurosurg Psychiatry (2003) 0.76
Pancreatic carcinoma: differences between patients with or without diabetes mellitus. Recenti Prog Med (1995) 0.76
[Alendronate-induced esophagitis. A report of 2 cases]. Recenti Prog Med (1997) 0.75
[Laparoscopy in the staging of lymphoma. Personal experience]. Recenti Prog Med (1988) 0.75
T-cell chronic lymphocytic leukemia. Report of a helper cell case. Haematologica (1983) 0.75
[Diagnostic and therapeutic considerations in Hashimoto's disease]. G Clin Med (1986) 0.75
[Preliminary clinical correlations with the receptor state determined by histochemical method in primary breast tumors and secondary lesions]. Pathologica (1986) 0.75
[Tumors of the retroperitoneal space]. Minerva Chir (1984) 0.75
[Peritoneovenous shunt complicating a glomerulonephritis associated with bacteremia. Description of a clinical case]. Recenti Prog Med (1989) 0.75
[The combined use of alpha-methyldopa and butizide in the treatment of arterial hypertension]. Clin Ter (1981) 0.75
[Stage classification of chronic lymphatic leukemia. A retrospective analysis of 263 cases]. Minerva Med (1990) 0.75
Polyneuritis after HD Ara-C therapy for malignant lymphoma. Ital J Neurol Sci (1992) 0.75
[Use of a non-steroid anti-inflammatory agent for topical administration in acute inflammatory phlebopathies of the lower extremities]. Minerva Cardioangiol (1975) 0.75
Disseminated encephalitis following streptococcal infection. Ital J Neurol Sci (1996) 0.75
[Hypercalcemic syndrome in malignant lymphomas. Review of the literature and clinical contribution]. Minerva Med (1983) 0.75
[Diagnostic laparosplenectomy in Hodgkin's disease: case reports and a critical evaluation (author's transl)]. Haematologica (1978) 0.75
EBVD and alternating MOPP/EBVD with or without localized field radiotherapy in advanced or unfavorably presenting Hodgkin's disease. Haematologica (1996) 0.75
[Therapy of hyperfunctioning thyropathies]. G Clin Med (1986) 0.75
Nitrite/nitrate balance during photoinduced cerebral ischemia in the rat determined by high-performance liquid chromatography with UV and electrochemical detection. J Chromatogr A (1998) 0.75
Electronic pupillometry for investigating pupil reactivity to different exteroceptive stimuli: applications and limits. Funct Neurol (1988) 0.75
[Malignant lymphomas of the thyroid gland: clinical contribution and review of literature]. Recenti Prog Med (1983) 0.75
[Primary lymphoma of the kidney. Description of a case and brief review of the literature]. Minerva Urol Nefrol (1993) 0.75
Diagnosis of spontaneous posterior fossa hemorrhage by computerized tomography. Riv Patol Nerv Ment (1979) 0.75
[Colliculus hemorrhage]. Rev Neurol (Paris) (1997) 0.75
[Splenic lymphoma with villous lymphocytes. A clinical case]. Minerva Med (1997) 0.75
[Malignant histiocytosis. Clinical contribution and review of the subject]. Minerva Med (1987) 0.75
[Digestive hemorrhage secondary to biliary ileus. Endoscopic diagnosis]. Minerva Chir (1993) 0.75
[Breath test with C 14-labeled aminopyrine in the study of hepatic function]. Recenti Prog Med (1981) 0.75
[DA 3177 a new synthetic spasmolytic agent in the management of spastic-dyskinetic conditions of the digestive tract. Double-blind controlled clinical trial]. Clin Ter (1979) 0.75
[Long-term course of acute and subacute thyroiditis (case contribution on 103 cases)]. G Clin Med (1985) 0.75
[Normally functioning goiter: reflections on the clinical course. A 30-year follow up]. Minerva Med (1988) 0.75
A cooperative study on ProMACE-CytaBOM in aggressive non-Hodgkin's lymphomas. Leuk Lymphoma (1994) 0.75
[Therapy of thrombophlebitis of the lower extremities with 2-(4-isobutylphenyl) propionic acid]. Minerva Cardioangiol (1975) 0.75
A case of parietal atrophy: etiopathogenetic evaluation. Acta Neurol (Napoli) (1993) 0.75
Low efficacy of thalidomide in improving response after induction in multiple myeloma patients who are candidates for high-dose therapy. Leuk Res (2007) 0.75
[Observations on the fertility of hyperthyroid patients treated with radioactive iodine (131I) and their daughters]. G Clin Med (1986) 0.75
[Hypotensive effect of saluretics]. Clin Ter (1982) 0.75